Literature DB >> 32028240

Protection against acute cerebral ischemia/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization.

Yule Wang1, Guangxu Xiao1, Shuang He1, Xinyan Liu1, Lin Zhu1, Xinyue Yang1, Yiqian Zhang2, John Orgah1, Yuxin Feng1, Xiaoying Wang3, Boli Zhang4, Yan Zhu5.   

Abstract

Cerebral ischemia/reperfusion injury (CI/RI) is a common feature of ischemic stroke, involving a period of impaired blood supply to the brain, followed by the restoration of cerebral perfusion through medical intervention. Although ischemia and reperfusion brain damage is a complex pathological process with an unclear physiological mechanism, more attention is currently focused on the neuroinflammatory response of an ischemia/reperfusion origin, and anti-inflammatory appears to be a potential therapeutic strategy following ischemic stroke. QiShenYiQi (QSYQ), a component-based Chinese medicine with Qi-tonifying and blood-activating property, has pharmacological actions of anti-inflammatory, antioxidant, mitochondrial protectant, anti-apoptosis, and antiplatelet aggregation. We have previously reported that the cardioprotective effect of QSYQ against ischemia/reperfusion injury is via improvement of mitochondrial functional integrity. In this research work, we aimed to investigate the possible mechanism involved in the neuroprotection of QSYQ in mice model of cerebral ischemia/reperfusion injury based on the inflammatory pathway. The cerebral protection was evaluated in the stroke mice after 24 h reperfusion by assessing the neurological deficit, cerebral infarction, brain edema, BBB functionality, and via histopathological assessment. TCM-based network pharmacology method was performed to establish and analyze compound-target-disease & function-pathway network so as to find the possible mechanism linking to the role of QSYQ in CI/RI. In addition, RT-qPCR was used to verify the accuracy of predicted signaling gene expression. As a result, improvement of neurological outcome, reduction of infarct volume and brain edema, a decrease in BBB disruption, and amelioration of histopathological alteration were observed in mice pretreated with QSYQ after experimental stroke surgery. Network pharmacology analysis revealed neuroinflammatory response was associated with the action of QSYQ in CI/RI. RT-qPCR data showed that the mice pretreated with QSYQ could significantly decrease IFNG-γ, IL-6, TNF-α, NF-κB p65, and TLR-4 mRNA levels and increase TGF-β1 mRNA level in the brain compared to the untreated mice after CI/RI (p < 0.05). In conclusion, our study indicated the cerebral protective effect of pretreatment with QSYQ against CI/RI, which may be partly related to its potential to the reduction of neuroinflammatory response in a stroke subject.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia/reperfusion injury; Neuroinflammatory response; QiShenYiQi; TCM-based network pharmacology

Year:  2020        PMID: 32028240     DOI: 10.1016/j.biopha.2020.109945

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway.

Authors:  Qing Miao; Ruihai Wang; Xiaoxin Sun; Song Du; Limei Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 2.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

3.  Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model.

Authors:  Yule Wang; Shuang He; Xinyan Liu; Zhixiong Li; Lin Zhu; Guangxu Xiao; Xiaoli Du; Hongxia Du; Wen Zhang; Yiqian Zhang; John Orgah; Yuxin Feng; Boli Zhang; Yan Zhu
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

Review 4.  The Influence of Mitochondrial-DNA-Driven Inflammation Pathways on Macrophage Polarization: A New Perspective for Targeted Immunometabolic Therapy in Cerebral Ischemia-Reperfusion Injury.

Authors:  Sihang Yu; Jiaying Fu; Jian Wang; Yuanxin Zhao; Buhan Liu; Jiahang Wei; Xiaoyu Yan; Jing Su
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

5.  QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice.

Authors:  Yang Ye; Quan Li; Chun-Shui Pan; Li Yan; Kai Sun; Xiao-Yi Wang; Shu-Qi Yao; Jing-Yu Fan; Jing-Yan Han
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

6.  Bibliometric analysis of China's contribution to the knowledge system of cerebrovascular intervention.

Authors:  Hongyu Ma; He Li; Peng Liu; Pei Liu; Xiaoxi Zhang; Yongxin Zhang; Zifu Li; Rui Zhao; Bo Hong; Jianmin Liu; Pengfei Yang
Journal:  Chin Neurosurg J       Date:  2021-12-19

7.  Network pharmacology approach to investigate the multitarget mechanisms of Zhishi Rhubarb Soup on acute cerebral infarction.

Authors:  Yuejia Shao; Yue Zhang; Rongrong Wu; Lurui Dou; Fengjiao Cao; Yuqing Yan; Yuming Tang; Chi Huang; Yang Zhao; Jinghua Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

8.  Atrial Natriuretic Peptide Antibody-Functionalised, PEGylated Multiwalled Carbon Nanotubes for Targeted Ischemic Stroke Intervention.

Authors:  Patrick P Komane; Pradeep Kumar; Yahya E Choonara
Journal:  Pharmaceutics       Date:  2021-08-28       Impact factor: 6.321

Review 9.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

10.  Health and related economic benefits associated with reduction in air pollution during COVID-19 outbreak in 367 cities in China.

Authors:  Tingting Ye; Suying Guo; Yang Xie; Zhaoyue Chen; Michael J Abramson; Jane Heyworth; Simon Hales; Alistair Woodward; Michelle Bell; Yuming Guo; Shanshan Li
Journal:  Ecotoxicol Environ Saf       Date:  2021-06-30       Impact factor: 6.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.